Niepubliczny Zakład Opieki Zdrowotnej Zakład Diagnostyki Medycznejsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-12-28
Share capital
5,000.00 PLN
Registered address
ul. Marszałkowska 9/1, 35-215 Rzeszów, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 379 days for 2019).

  • 2025not filed
  • 202415/07/2025
  • 202313/08/2024
  • 202202/02/2024
  • 202114/07/2022
  • 202029/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Human health activities1,944 / 2,926
Top 66%
Top 66%
Voivodeship · Podkarpackie11,520 / 16,367
Top 70%
Country · Poland344,528 / 495,976
Top 69%

Results vs industry

Revenue
This companyUSD 43.45kMedianUSD 91.71kAverageUSD 1.38m
Net profit
This companyUSD -4.08kMedianUSD 2.67kAverageUSD 145.91k
Operating costs
This companyUSD 47.09kMedianUSD 82.72kAverageUSD 1.19m
Assets
This companyUSD 12.20kMedianUSD 39.39kAverageUSD 950.50k

Authorized Representatives

Radosław Bogusław Chlebekage 29 – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
100$1,350.62100%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

FAQ

Last updated: 2026-10-07